Received Sep 24, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA MNEXSPIKE)) | MODERNA | UNK | 3052030 | IM |
sudden vision loss and blurry in the distance; eye pain; This spontaneous case was reported by a pharmacist and describes the occurrence of SUDDEN VISUAL LOSS (sudden vision loss and blurry in the distance) in a 64-year-old female patient who received mRNA-1283 (MNEXSPIKE PFS) (batch no. 3052030) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below. No medical history provided. Concomitant products included Measles vaccine, Mumps vaccine, Rubella vaccine (Mmr) for an unknown indication. On 09-Sep-2025, the patient received dose of mRNA-1283 (MNEXSPIKE PFS) (Intramuscular use) .2 milliliter. On 11-Sep-2025, after starting mRNA-1283 (MNEXSPIKE PFS), the patient experienced SUDDEN VISUAL LOSS (sudden vision loss and blurry in the distance) (seriousness criterion medically significant). In September 2025, the patient experienced EYE PAIN (eye pain). At the time of the report, SUDDEN VISUAL LOSS (sudden vision loss and blurry in the distance) and EYE PAIN (eye pain) had not resolved. For mRNA-1283 (MNEXSPIKE PFS) (Intramuscular use), the reporter did not provide any causality assessments. Patient had received MMR vaccine week prior to mNEXSPIKE. The patient received the vaccine on 09-Sep-2025 and on 11-Sep-2025, patient had sudden vision loss. Patient woke up at 3 am and read the side effects and had not noticed that before (the vision loss symptom) when she read the sheet. Her biggest question right then was whether her symptoms were temporary or permanent. She could not read or type. Patient went to the eye doctor on 12-Sep-2025 at 8 o'clock and had been using eyeglasses that were like a reader 2.25 and it jumped to a 4.75 recommendation in layman's terms. Her eye doctor said that she had never seen such vision loss so fast. It was reported that things were blurry, and she had eye pain and that it was sudden vision loss and blurry in the distance. It was also hard to read street signs, and it was really debilitating. Patient could not read the tablets to verify the tablets and pills and could not read prescriptions. She was in the middle of getting strong eyeglasses but if that ended up being temporary or went away in a few days, she did not want to order glasses. No specific treatment drugs were reported.; Reporter's Comments: The benefit-risk relationship of product is not affected by this report.
Mmr